(Q35229174)

7 August 2017

1 reference

title

The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin (English)

1 reference

7 August 2017

The New Macrolide Antibiotics: Azithromycin, Clarithromycin, Dirithromycin, and Roxithromycin (English)

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318761

12 September 2022

author name string

N. Bahal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318761

12 September 2022

M. C. Nahata

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318761

12 September 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

full work available at URL

7 August 2017

http://www.theannals.com/cgi/content/abstract/26/1/46

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318761

http://journals.sagepub.com/doi/pdf/10.1177/106002809202600112

12 September 2022

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

Annals of Pharmacotherapy

5 December 2023

published in

1 reference

7 August 2017

26

1 reference

7 August 2017

1

1 reference

7 August 2017

46-55

1 reference

New directions for macrolide antibiotics: structural modifications and in vitro activity

7 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

The renaissance of erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

In-vitro activity of azithromycin against Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

In vitro and in vivo activities of clarithromycin against Mycobacterium avium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Comparative pharmacokinetics of macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Roxithromycin: a pharmacokinetic review of a macrolide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Tissue distribution of roxithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Pharmacokinetics of roxithromycin in renal and hepatic failure and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Azithromycin in the treatment of sexually transmitted disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Comparative efficacy and tolerability of clarithromycin and amoxycillin in the treatment of out-patients with acute maxillary sinusitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Comparison of the clinical and bacteriological efficacy of clarithromycin and erythromycin in the treatment of streptococcal pharyngitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Clarithromycin versus penicillin in the treatment of streptococcal pharyngitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Roxithromycin, a new macrolide antibiotic, in the treatment of infections in the lower respiratory tract: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Comparative efficacy and toxicity of roxithromycin and erythromycin ethylsuccinate in the treatment of streptococcal pharyngitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Azithromycin (CP-62,993) in acute exacerbations of chronic bronchitis: an open clinical, microbiological and pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Roxithromycin in nongonococcal urethritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

An evaluation of tolerance of roxithromycin in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600112

Proceedings of the staff meetings. Mayo Clinic

21 January 2018

1

27

285

Heilman FR

1952

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

Antibiotica et chemotherapia. Fortschritte. Advances. Progres

5 December 2023

2

2

281

McGuire JM

1952

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

Erythromycin

4

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

19

42

19

Casal M.

1988

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

The pharmacokinetics of azithromycin in human serum and tissues

5 December 2023

21

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

22

42

51

Tremblay D

1988

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

Single oral dose pharmacokinetics of erythromycin and roxithromycin and the effects of chronic dosing

5 December 2023

23

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

24

42

54

Zini R

1988

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

Drug Metabolism and Disposition

5 December 2023

28

18

441

Ferrero JL

1990

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

Macrolide progress

29

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

31

42

61

Tremblay D

1988

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

32

42

63

Lebrec D

1988

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

A comparative study of clarithromycin and penicillin VK in the treatment of outpatients with streptococcal pharyngitis

5 December 2023

39

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

Efficacy of clarithromycin against Mycoplasma pneumoniae

5 December 2023

40

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia

5 December 2023

42

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis

5 December 2023

44

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

Roxithromycin in skin and soft tissue infections

5 December 2023

46

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

Roxithromycin in the therapy of Streptococcus pyogenes throat infections

5 December 2023

48

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

51

42

91

Rahlwes M

1988

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

52

42

92

MacLoughlin GFF

1988

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

53

42

102

Humbrechts JM

1988

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

54

42

98

Bertrand A

1988

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

55

42

100

Marsac J

1988

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

56

42

115

Stamboulian D

1988

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

57

42

108

Morel P

1988

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

59

42

113

Casellas JM

1988

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

Efficacy and safety of roxithromycin in treating paediatric patients. A European multicentre study

5 December 2023

60

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

Gastrointestinal side effects with erythromycin preparations

5 December 2023

61

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

Changes in the steady-state pharmacokinetics of theophylline during treatment with dirithromycin

5 December 2023

64

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

A study of the interaction of roxithromycin with theophylline and carbamazepine

5 December 2023

65

1 reference

https://api.crossref.org/works/10.1177/106002809202600112

5 December 2023

Identifiers

1 reference

7 August 2017

1 reference